Welcome to our dedicated page for Graftech International SEC filings (Ticker: EAF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
GrafTech International Ltd. SEC filings document financial results, governance actions, and stockholder voting matters for its graphite electrode and petroleum needle coke business. Form 8-K reports furnish earnings releases covering operating results, financial condition, liquidity, sales volume, cost trends, and related exhibits.
Proxy and annual meeting filings cover director elections, auditor ratification, executive compensation votes, advisory vote frequency, and common stock voting mechanics. Material-event filings also record board composition changes and amendments to prior annual meeting vote disclosures.
GrafTech International Ltd. entered into an Equity Distribution Agreement with Evercore Group L.L.C., allowing it to sell shares of common stock from time to time in an at-the-market offering with an aggregate offering price of up to $50,000,000.
Evercore will act as sales agent and may receive a commission of up to 3.0% of gross offering proceeds. The program runs under GrafTech’s effective Form S-3 shelf registration and can be terminated at any time by either party. Any net proceeds are intended for general corporate purposes, including operating needs, refinancing debt, capital spending, and potential acquisitions or joint ventures.
GrafTech International Ltd. is registering an at-the-market equity program to offer and sell common stock having an aggregate offering price of $50,000,000 pursuant to an Equity Distribution Agreement dated May 29, 2026.
The sales may be made from time to time on or through the NYSE or other trading venues, directly to the agent as principal, in block or privately negotiated transactions, and settlement is expected to occur on the first trading day following each sale. The company stated 26,047,884 shares outstanding as of May 28, 2026 and illustrates an assumed issuance of 5,000,000 shares in the offering for illustrative dilution purposes.
GrafTech International Ltd. filed a shelf registration on to offer up to $150,000,000 aggregate initial offering price of securities, including common stock, preferred stock, debt securities, depositary shares, warrants, purchase contracts and units. The prospectus describes general terms; specific offerings and distribution methods will be set in prospectus supplements.
The prospectus states GrafTech’s common stock is listed on the NYSE under the symbol EAF and cites a last reported sale price of $8.61 per share on . Authorized capitalization includes 300,000,000 common shares and 30,000,000 preferred shares. Use of proceeds is for general corporate purposes, including refinancing debt, capital expenditures, share repurchases or other strategic opportunities.
Marathon Asset Management filings report beneficial ownership stakes in GrafTech International Ltd. The filing states Marathon GP, Marathon, Bruce Richards and Louis Hanover each have sole voting and dispositive power over 1,211,615 shares of Common Stock (4.7%), and MDCF II holds 923,084 shares (3.5%), as of 03/31/2026. The report clarifies these holdings arise from Marathon’s role as investment manager and notes the filing is not an admission of beneficial ownership for Section 13 purposes.
Germain Jean-Marc reported acquisition or exercise transactions in this Form 4 filing.
GRAFTECH INTERNATIONAL LTD director Jean-Marc Germain received a grant of 11,173.1844 Deferred Restricted Stock Units (DRSUs). Each DRSU represents a right to receive one share of EAF common stock. Following this grant, he holds 33,246.9324 DRSUs directly. The DRSUs generally vest on November 7, 2026 and will be settled in common stock after his board service ends, either in a lump sum that year or in five annual installments, according to his prior election.
Shivaram Sachin M reported acquisition or exercise transactions in this Form 4 filing.
GRAFTECH INTERNATIONAL LTD director Sachin M. Shivaram received a grant of 11,173.1844 Deferred Restricted Stock Units (DRSUs). Each DRSU represents a contingent right to receive one share of EAF common stock. Following this award, he holds 24,853.1844 DRSUs directly.
The DRSUs generally vest on November 7, 2026. Once vested, they will be settled in whole shares of common stock and delivered either in a single lump after his board service ends or in five annual 20% installments, depending on his prior election.
Fine Debra reported acquisition or exercise transactions in this Form 4 filing.
GrafTech International director Debra Fine reported a compensation-related equity grant. She received 11,173.1844 Deferred Restricted Stock Units (DRSUs), each representing a contingent right to one share of EAF common stock. These DRSUs generally vest on November 7, 2026 and will be settled in whole shares after she leaves the board. Following this award, her reported balance in these derivative units is 33,246.9324.
Roegner Eric V reported acquisition or exercise transactions in this Form 4 filing.
GrafTech International Ltd. director equity grant: Director Eric V. Roegner received an award of 11,173.1844 Deferred Restricted Stock Units (DRSUs), each representing a contingent right to one share of EAF common stock. Following this grant, he holds 22,701.1844 DRSUs in total.
The DRSUs generally vest on November 7, 2026. After vesting, they will be settled in whole shares of common stock and delivered to him after his service as a director ends, but no later than the end of the calendar year in which that termination occurs.
Keizer Henry R. reported acquisition or exercise transactions in this Form 4 filing.
GrafTech International Ltd. director Henry R. Keizer received a grant of deferred restricted stock units (DRSUs) tied to EAF common stock. The award covers 11,173.1844 DRSUs, each representing a contingent right to receive one share of common stock.
Following this grant, Keizer holds 30,849.1844 DRSUs in total. The new DRSUs generally vest on November 7, 2026. Once vested, they will be settled in whole shares of common stock and delivered after Keizer’s service as a director ends, and no later than the end of the calendar year in which that termination occurs.